POAI News and Press, Predictive Oncology Inc. From 05/16/22

Predictive Oncology (NASDAQ: POAI) , a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into definitive agreements with several institutional investors for the issuance and sale o...

Predictive Oncology (NASDAQ:POAI) enters issuance and sale agreement regarding certain stock purchase warrants, that are expected to result in gross proceeds totaling ~$7.2M. In the first offering, company has entered into definitive agreements with several institutional investors f...

EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discover...

Predictive Oncology (NASDAQ: POAI) , a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released financial results from its first quarter, the period ending March 31, 2022. Highlights from the report i...

Predictive Oncology press release (NASDAQ:POAI): Q1 GAAP EPS of -$0.05 misses by $0.01. Revenue of $0.31M (+10.7% Y/Y) misses by $0.69M. For further details see: Predictive Oncology GAAP EPS of -$0.05 misses by $0.01, revenue of $0.31M misses by $0.69M

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by Predictive Oncology Inc. (NASDAQ: POAI) today, disclosing the results for the quarter ende...

Predictive Oncology (NASDAQ: POAI) , a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop optimal cancer therapies, today announced that Theresa Ferguson has been named senior director of marketing. As the company’s senior marketing l...

EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director of Marketing. As Predictive Oncology’s senior marketing leader, Ferguson steps in as the company begins commercialization of i...

Predictive Oncology (NASDAQ: POAI) , a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is reporting its financial and corporate results for the year ended Dec. 31, 2021. Highlights of the report include p...

Predictive Oncology press release (NASDAQ:POAI): FY GAAP EPS of -$0.36 misses by $0.12. Revenue of $1.42M (+13.6% Y/Y) misses by $2M. Shares -2.66% AH. For further details see: Predictive Oncology GAAP EPS of -$0.36 misses by $0.12, revenue of $1.42M misses by $2M